4 - Supportive Care for Perinatal Substance Use
Key:
Complete
Next
Failed
Available
LockedThroughout this session, participants will delve into the stigma and marginalization associated with addiction in pregnancy, and how both patients and medical professionals suffer from the lack of addiction medicine training in healthcare. This presentation will explore advances in the science and the neurobiology of Medication for Addiction Treatment (MAT) that will strengthen the work among practitioners, community providers and court related participants in the exploration of approaches that support families involving pregnant people with opioid and other substance use disorders well as children exposed prenatally.
Objectives:
- Participants will gain an understanding of the neurobiology of addiction
- Participants will review the history of addiction treatment structure in our country and how it should be adapted to incorporate evidence-based approaches
- Participants will understand appropriate screening tools and techniques for identifying substance use in pregnancy
- Participants will learn about the newest evidence-based assessment tools for treating neonatal withdrawal
- Participants will understand components of family-centered care that can decrease length-of-stay and exposure to morphine
Kaitlan Baston, MD, MSc, DFASAM (she/her/hers)
Medical Director of Addiction Medicine
Cooper University Health Care
Kaitlan Baston, MD, MSc is the Medical Director of Addiction Medicine at Cooper University Hospital in Camden, NJ, and Assistant Professor at Cooper Medical School of Rowan University. She is dual boarded in Family Medicine and Addiction Medicine. Kaitlan obtained a master's degree in Neuroscience from King’s College London, and then graduated from Jefferson Medical College in Philadelphia. She attended medical school fueled by inequities in the healthcare system. Through her work with immigrant and homeless populations and international public health projects, her idealizations directed her to a career in primary care. She pursued full spectrum family medicine training with obstetrics in Seattle, Washington, and received her waiver to prescribe buprenorphine for patients with opioid dependence early in her training. This work illuminated the stigma and marginalization associated with addiction, and Kaitlan observed that both patients and medical professionals suffered from the lack of addiction medicine training in healthcare. With the goals of community outreach, healthcare education and hospital system improvement, she completed an American Board of Addiction Medicine (ABAM) accredited addiction medicine fellowship. Following her training, she returned to the East Coast to begin her career. Kaitlan became the Medical Director of Cooper’s Addiction Medicine Program in 2015. She currently practices in their Urban Health Institute, working with an interdisciplinary team of like-minded, driven individuals dedicated to making change in Camden. She strives not only to create a home for patients with substance use disorders within the medical system, but also to end the stigma of addiction in society and to ensure that all patients suffering from substance use disorders are offered treatments that can allow them to live full and satisfying lives.
